Good Neighbor Pharmacy
Source filing: WI · filed 2025-12-19
Item 5 — Initial franchise fee
Not disclosed
Item 6 — Recurring fees (royalty & advertising)
Not disclosed in extracted fee schedule — see FDD Item 6.
Item 7 — Estimated initial investment (total)
$278,797 [p.28 · WI · 2025-12-19] – $575,205 [p.28 · WI · 2025-12-19]
Base single-franchise offering as stated in the FDD's total row. Multi-unit or area-development formats are not broken out here.
Item 20 — Outlets
| Franchised outlets at start of year | 2,294 [p.55 · WI · 2025-12-19] |
|---|---|
| Franchised outlets at end of year | 2,204 [p.55 · WI · 2025-12-19] |
| Net change in franchised outlets | -90 [p.55 · WI · 2025-12-19] |
| Transfers | 45 [p.60 · WI · 2025-12-19] |
| Terminations | 0 [p.65 · WI · 2025-12-19] |
| Non-renewals | 25 [p.65 · WI · 2025-12-19] |
| Ceased operations (other) | Not disclosed |
| Company-owned outlets at end of year | 0 [p.55 · WI · 2025-12-19] |
Item 19 — Financial performance representation
The filing's Item 19 contains no cohort eligible for headline presentation under this site's rules (franchised population, gross revenue/sales, annual, not a ranked subset).
All disclosed cohorts (8)
| Cohort | Outlets | Average | Median | High | Low |
|---|---|---|---|---|---|
| GNP Premier Pharmacies - PRxO Generics five-star rebate Q2 2025 scoring 4.5 and higher Q2 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Premier Pharmacies - PRxO Generics five-star rebate all payout tiers Q2 2025 Q2 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Pharmacies - unsaleable returns recouped FY2025 October 1, 2024 - September 30, 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Premier Pharmacies - private label product purchases per month September 2024 - August 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Premier Pharmacies - pet health purchases per month September 2024 - August 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Premier Pharmacies - shelf talker sales December 2024 - July 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Premier Pharmacies - Humana MAPD Quality Improvement Program performance dollars January 2024 - July 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| GNP Premier Pharmacies working with Business Coaching Associate - Humana Quality Improvement Program payout increase January 2024 - July 2024 vs. January 2025 - July 2025 excluded: failed consistency checks |
Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
“Some outlets sold these amounts. Your individual results may differ. There is no assurance you will sell as much.” [p.54 · WI · 2025-12-19]
Extraction notes
- Item 7 totals were extracted with model assistance and verified against the cited page.